281 related articles for article (PubMed ID: 17591770)
21. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
Jank T; Aktories K
Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
[TBL] [Abstract][Full Text] [Related]
22. Autoprocessing of the Vibrio cholerae RTX toxin by the cysteine protease domain.
Sheahan KL; Cordero CL; Satchell KJ
EMBO J; 2007 May; 26(10):2552-61. PubMed ID: 17464284
[TBL] [Abstract][Full Text] [Related]
23. Molecular mode of action of the large clostridial cytotoxins.
Just I; Hofmann F; Aktories K
Curr Top Microbiol Immunol; 2000; 250():55-83. PubMed ID: 10981357
[No Abstract] [Full Text] [Related]
24. Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.
Alvin JW; Lacy DB
J Struct Biol; 2017 Jun; 198(3):203-209. PubMed ID: 28433497
[TBL] [Abstract][Full Text] [Related]
25. Super toxins from a super bug: structure and function of Clostridium difficile toxins.
Davies AH; Roberts AK; Shone CC; Acharya KR
Biochem J; 2011 Jun; 436(3):517-26. PubMed ID: 21615333
[TBL] [Abstract][Full Text] [Related]
26. A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity.
Zhang Y; Shi L; Li S; Yang Z; Standley C; Yang Z; ZhuGe R; Savidge T; Wang X; Feng H
PLoS One; 2013; 8(3):e58634. PubMed ID: 23484044
[TBL] [Abstract][Full Text] [Related]
27. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
Chen S; Sun C; Wang H; Wang J
Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.
Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A
Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648
[TBL] [Abstract][Full Text] [Related]
29. Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells.
Pfeifer G; Schirmer J; Leemhuis J; Busch C; Meyer DK; Aktories K; Barth H
J Biol Chem; 2003 Nov; 278(45):44535-41. PubMed ID: 12941936
[TBL] [Abstract][Full Text] [Related]
30. Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins.
Shen A; Lupardus PJ; Gersch MM; Puri AW; Albrow VE; Garcia KC; Bogyo M
Nat Struct Mol Biol; 2011 Mar; 18(3):364-71. PubMed ID: 21317893
[TBL] [Abstract][Full Text] [Related]
31. Delineation of the catalytic domain of Clostridium difficile toxin B-10463 to an enzymatically active N-terminal 467 amino acid fragment.
Wagenknecht-Wiesner A; Weidmann M; Braun V; Leukel P; Moos M; von Eichel-Streiber C
FEMS Microbiol Lett; 1997 Jul; 152(1):109-16. PubMed ID: 9228777
[TBL] [Abstract][Full Text] [Related]
32. Toward a structural understanding of Clostridium difficile toxins A and B.
Pruitt RN; Lacy DB
Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
[TBL] [Abstract][Full Text] [Related]
33. A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins.
Busch C; Hofmann F; Selzer J; Munro S; Jeckel D; Aktories K
J Biol Chem; 1998 Jul; 273(31):19566-72. PubMed ID: 9677381
[TBL] [Abstract][Full Text] [Related]
34. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
Zeiser J; Gerhard R; Just I; Pich A
J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
[TBL] [Abstract][Full Text] [Related]
35. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
[No Abstract] [Full Text] [Related]
36. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
Faust C; Ye B; Song KP
Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
[TBL] [Abstract][Full Text] [Related]
37. Comparison of wild type with recombinant Clostridium difficile toxin A.
Gerhard R; Burger S; Tatge H; Genth H; Just I; Hofmann F
Microb Pathog; 2005; 38(2-3):77-83. PubMed ID: 15748809
[TBL] [Abstract][Full Text] [Related]
38. Human alpha-defensins inhibit Clostridium difficile toxin B.
Giesemann T; Guttenberg G; Aktories K
Gastroenterology; 2008 Jun; 134(7):2049-58. PubMed ID: 18435932
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile toxins A and B are cation-dependent UDP-glucose hydrolases with differing catalytic activities.
Ciesla WP; Bobak DA
J Biol Chem; 1998 Jun; 273(26):16021-6. PubMed ID: 9632652
[TBL] [Abstract][Full Text] [Related]
40. The combined repetitive oligopeptides of clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation.
Olling A; Hüls C; Goy S; Müller M; Krooss S; Rudolf I; Tatge H; Gerhard R
Toxins (Basel); 2014 Jul; 6(7):2162-76. PubMed ID: 25054784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
